Credevo conducted a feasibility on AML (Acute Myeloid Leukemia) and we received a great response from Investigator/Sites. Study details The study was Phase 1 & Phase 2, Interventional, Multi-center, Randomised, Open label, Single-arm, Multiple ascending dose with patient criteria of Acute Myeloid Leukemia non eligible for intensive chemotherapy as first-line, second-line, or... Read more